The trademark EXIMUS was filed by Catus Biotech GmbH, a corporation established under the laws of the Federal Republic of Germany (the "Applicant") and Maximilian Stricker, a national of the Federal Republic of Germany (the "Co-Applicant", and jointly with the "Applicant" referred to as the "Applicants" going forward). The application was published for oppositions on September 21, 2021, and received one opposition filed on October 11, 2021 by ABEILLES SANTE on Likelihood of confusion. the opponent was represented by A.P.I. CONSEIL and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued October 11, 2021
The application was filed in German, and German was also language of all opposition proceedings (English was selected as the second language).
Goods And Services
The mark was filed in class 1 with following description of goods:
Industrial chemicals, Especially Nutritional solutions for cell cultures, Sera, Antigens, antiserums and Chemiluminescent substances for serological diagnostics
Biological preparations for use in industry and science, Especially Nutritional solutions for cell cultures, Sera, Antigens, antiserums and Chemiluminescent substances for serological diagnostics
Biotechnological preparations for industrial use and Science, Especially Nutritional solutions for cell cultures, Sera, Antigens, antiserums and Chemiluminescent substances for serological diagnostics
Chemicals used in science, Especially Nutritional solutions for cell cultures, Sera, Antigens, antiserums and Chemiluminescent substances for serological diagnostics
Biotechnological agents for industrial use and Science, Especially Nutritional solutions for cell cultures, Sera, Antigens, antiserums and Chemiluminescent substances for serological diagnostics